## **Core Concept**
The treatment of maxillary sinus carcinoma, particularly in stage III (T3 N0 M0), involves a multidisciplinary approach. Maxillary sinus cancer is a type of head and neck cancer, and its staging is based on the tumor's size, lymph node involvement, and distant metastasis. Stage III indicates a locally advanced tumor without lymph node involvement or distant metastasis.

## **Why the Correct Answer is Right**
For stage III maxillary sinus carcinoma (T3 N0 M0), the treatment of choice often involves a combination of surgery and radiotherapy. Surgery aims to remove the tumor completely, and radiotherapy is used to control microscopic disease and reduce the risk of local recurrence. The correct answer, **C.**, likely represents this combined modality approach, which is commonly recommended for locally advanced cancers of the maxillary sinus to improve local control and survival rates.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might represent a single modality treatment, such as surgery alone. However, for stage III maxillary sinus carcinoma, a single modality treatment is generally considered insufficient due to the locally advanced nature of the disease.
- **Option B:** This could represent radiotherapy alone, which might not be adequate for a T3 tumor due to the tumor's size and potential for local invasion.
- **Option D:** This option might suggest chemotherapy alone or a different treatment approach not typically recommended as the primary treatment for stage III maxillary sinus carcinoma.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the treatment of maxillary sinus carcinoma often requires a multidisciplinary team, including surgeons, radiation oncologists, and medical oncologists. For locally advanced disease like stage III, combined modality therapy, typically surgery followed by radiotherapy, is crucial for optimizing outcomes.

## **Correct Answer:** **C.**